6 news items
MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy
INCY
JAZZ
MIRA
23 Jul 24
with anticipation, hopeful for a new, effective weapon against hard-to-treat cancers. With ongoing trials and a commitment to innovative cancer
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
MIRA
22 Jul 24
are committed to advancing Ketamir-2 towards clinical trials and making this innovative treatment available to patients in need."About MIRA
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
MIRA
29 May 24
represents a significant value proposition for our company. We remain committed to advancing it through the development pipeline for treating these diseases
MIRA Pharmaceuticals Discusses With Memorial Sloan Kettering To Collaborate On A Preclinical Cancer Pain Model Utilizing The Co's Novel Oral Ketamine Analog
MIRA
21 May 24
. This underscores MIRA's commitment to broadening the potential uses of its novel compound beyond treatment-resistant depression, major depressive disorder
MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog
MIRA
21 May 24
of the potential for Ketamir-2. This underscores MIRA's commitment to broadening the potential uses of its novel compound beyond treatment-resistant
4px2xanrrzfpt0pflimcjm8kvprn
MIRA
20 May 24
collaboration with Pharmaseed and Biotrial underscores our commitment to advancing Ketamir-2 towards clinical development in humans and addressing the urgent
- Prev
- 1
- Next